Clinical determinants of calcineurin inhibitor disposition: a mechanistic review
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
The calcineurin inhibitors (CNIs) tacrolimus and cyclosporine are widely used immunosuppressive drugs characterized by high pharmacokinetic and pharmacodynamic variability, both between and within patients. CNIs are highly lipophilic, poorly soluble, undergo extensive first-pass metabolism and are cleared by the liver. In both gut and liver, CNIs are substrates for the cytochrome P450 (CYP) enzymes 3A4 and 3A5 as well as the P-glycoprotein (P-gp) transporter, whose functions are determined by a complex interplay between genetic polymorphisms, the inductive or inhibitory effects of many drugs, herbs, food constituents and endogenous substances such as uremic toxins in case of end-stage renal disease. The current literature is reviewed for all common clinical determinants of variability in CNI disposition such as food intake, diarrhea and other intestinal pathology, anemia, hypoalbuminemia, hyperlipidemia, liver and kidney disease, aging, ethnicity, formulation and time post-transplant, focusing on the underlying mechanisms. Drugs and herb- and food constituents mainly interact with CNIs at the gut level by affecting bioavailability, with interactions generally being much more pronounced in case of oral compared with intravenous co-administration. Cyclosporine disposition is less susceptible to these interactions compared with tacrolimus, possibly because cyclosporine is itself a moderately strong CYP3A4- and strong P-gp inhibitor, blunting the effect of additional inhibitors. P-gp also has a major role in limiting distribution of CNI to tissues such as the brain, placenta, lymphocytes and kidney. Inactivating polymorphisms and inhibition of P-gp have the potential to significantly increase CNI exposure in these tissues with possible implications for toxicity and efficacy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding
Aller, S. G., Yu, J., Ward, A., Weng, Y., Chittaboina, S., Zhuo, R., Harrell, P. M., Trinh, Y. T., Zhang, Q., Urbatsch, I. L., et al. (2009) · Science · doi:10.1126/science.1168750 · Cited by 1,929 · cited 1×
“Whether a compound is a substrate and/or inhibitor of P-gp depends on its ability to engage in hydrophobic and aromatic interactions, the strength of the hydrogen bonds it can form and the distance between the electron donor groups that form these bonds (Aller et al., 2009; Seelig, 1998).”
BackgroundSun, M., Kingdom, J., Baczyk, D., Lye, S. J., Matthews, S. G., & Gibb, W. (2006) · Placenta · doi:10.1016/j.placenta.2005.05.007 · Cited by 223
Gut Microbiota and Tacrolimus Dosing in Kidney Transplantation
Lee, J. R., Muthukumar, T., Dadhania, D., Taur, Y., Jenq, R. R., Toussaint, N. C., Ling, L., Pamer, E., & Suthanthiran, M. (2015) · PLOS ONE · doi:10.1371/journal.pone.0122399 · Cited by 211
Wu, X., Li, Q., Xin, H., Yu, A., & Zhong, M. (2005) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-005-0952-3 · Cited by 90
Effect of berberine on the pharmacokinetics of substrates of CYP3A and P-gp
Qiu, W., Jiang, X. H., Liu, C. X., Ju, Y., & Jin, J. X. (2009) · Phytotherapy Research · doi:10.1002/ptr.2808 · Cited by 64
Cited by
Neuberger, J. M., Bechstein, W. O., Kuypers, D. R. J., Burra, P., Citterio, F., De Geest, S., Duvoux, C., Jardine, A. G., Kamar, N., Krämer, B. K., et al. (2017) · Transplantation · doi:10.1097/tp.0000000000001651 · Cited by 315
Self-citationMarijuana use in transplantation: a call for clarity
Levi, M. E., Montague, B. T., Thurstone, C., Kumar, D., Huprikar, S. S., Kotton, C. N., & the Executive Committee of the Infectious Diseases Community of Practice of the American Society of Transplantation (2019) · Clinical Transplantation · doi:10.1111/ctr.13456 · Cited by 38
The impact of tacrolimus exposure on extrarenal adverse effects in adult renal transplant recipients
Campagne, O., Mager, D. E., Brazeau, D., Venuto, R. C., & Tornatore, K. M. (2019) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13811 · Cited by 31
Metadata
- Authors
- Vanhove, T., Annaert, P., & Kuypers, D. R. J.
- Venue
- Drug Metabolism Reviews
- Publisher
- Informa UK Limited
- Published
- 2016-01-02
- Volume
- 48
- Issue
- 1
- Pages
- 88-112
- ISSN
- 0360-2532 (ISSN-L)
- 1097-9883
- OpenAlex
- W2296407051
- Cited by
- 171
- References
- 5
- FWCI
- 21.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.